SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Tuesday 10 November 2026
News from the 24 hours to Tuesday morning, 10 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage was thin, with the only relevant item being a piece on another wound care stock that refers to a collapsed merger involving Smith & Nephew. That reference leans negative.
What drove it
- collapsed merger
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Wed 4 Nov | −1.7 | 4 |
| Thu 5 Nov | −8.3 | 19 |
| Fri 6 Nov | −6.8 | 5 |
| Sat 7 Nov | −5.3 | 2 |
| Mon 9 Nov | +0.8 | 1 |
| Tue 10 Nov | −5.0 | 1 |
| Thu 12 Nov | +0.8 | 5 |
| Fri 13 Nov | −5.7 | 3 |
1 story · 1 headline · strongest first
Pharma and healthcare on 10 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Wound care stock viewed after Smith+Nephew merger collapse −5.81 headline today · A Benzinga piece looks at a wound care stock following the collapse of the Smith+Nephew merger. | ||
| −5.8 | Refers to a failed large merger involving the company, though focus is another stock. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.